Sanofi 提交 6-K，披露德国胰岛素生产设施奠基新闻稿
6-K - Sanofi (0001121404) (Filer)
Sanofi 于 2026 年 10 月提交 6-K，称公司已发布一份新闻稿，并将其作为附件纳入文件。附件新闻稿日期为 10 月 19 日，标题称 Sanofi 在德国一座新型胰岛素生产设施举行奠基仪式。
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number: 001-31368
SANOFI
(Translation of registrant’s name into English)
46, avenue de la Grande Armée, 75017 Paris, FRANCE
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
In October 2026, Sanofi published the press release attached hereto as Exhibit 99.1 which is incorporated herein by reference.
Exhibit Index
| Exhibit No. |
Description | |
| Exhibit 99.1 |
Press Release dated October 19, 2026: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany | |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Dated: October 26, 2026 | SANOFI | |||||
| By | /s/ Alexandra Roger | |||||
| Name: Alexandra Roger | ||||||
| Title: Head of Legal Corporate & Finance | ||||||
3
来源：SEC EDGAR · 本站存档